| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.82e-05 | 102 | 31 | 4 | GO:0005249 | |
| GeneOntologyMolecularFunction | potassium channel activity | 4.43e-05 | 128 | 31 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 8.65e-05 | 152 | 31 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.24e-04 | 167 | 31 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.71e-04 | 343 | 31 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.73e-04 | 182 | 31 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.81e-04 | 184 | 31 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.51e-04 | 459 | 31 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.91e-04 | 465 | 31 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 1.19e-03 | 525 | 31 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.20e-03 | 526 | 31 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.69e-03 | 334 | 31 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.86e-03 | 1180 | 31 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 2.39e-03 | 1233 | 31 | 7 | GO:0140677 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.59e-03 | 627 | 31 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | transporter activity | 3.07e-03 | 1289 | 31 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.32e-03 | 664 | 31 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.82e-03 | 758 | 31 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 7.03e-03 | 793 | 31 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 9.09e-03 | 279 | 31 | 3 | GO:0005096 | |
| GeneOntologyBiologicalProcess | regulation of action potential firing threshold | 7.90e-06 | 3 | 34 | 2 | GO:0099611 | |
| GeneOntologyBiologicalProcess | apoptosome assembly | 7.90e-06 | 3 | 34 | 2 | GO:0097314 | |
| GeneOntologyBiologicalProcess | substantia propria of cornea development | 7.90e-06 | 3 | 34 | 2 | GO:1903701 | |
| GeneOntologyBiologicalProcess | action potential initiation | 2.63e-05 | 5 | 34 | 2 | GO:0099610 | |
| GeneOntologyBiologicalProcess | inhibitory chemical synaptic transmission | 5.51e-05 | 7 | 34 | 2 | GO:0098977 | |
| GeneOntologyBiologicalProcess | psychomotor behavior | 5.51e-05 | 7 | 34 | 2 | GO:0036343 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 3.12e-04 | 16 | 34 | 2 | GO:0098976 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 1.25e-05 | 91 | 33 | 4 | GO:0008076 | |
| GeneOntologyCellularComponent | potassium channel complex | 2.12e-05 | 104 | 33 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | node of Ranvier | 4.51e-04 | 20 | 33 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | cation channel complex | 4.93e-04 | 235 | 33 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | axon initial segment | 9.55e-04 | 29 | 33 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.28e-03 | 785 | 33 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | membrane protein complex | 1.88e-03 | 1498 | 33 | 8 | GO:0098796 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.85e-03 | 378 | 33 | 4 | GO:0034702 | |
| HumanPheno | Facial cyanosis | 6.01e-06 | 2 | 13 | 2 | HP:0034031 | |
| HumanPheno | Circumoral cyanosis | 6.01e-06 | 2 | 13 | 2 | HP:0032556 | |
| HumanPheno | Focal EEG discharges with secondary generalization | 3.60e-05 | 4 | 13 | 2 | HP:0011188 | |
| HumanPheno | Focal head nodding automatism seizure | 5.99e-05 | 5 | 13 | 2 | HP:0032906 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 5.99e-05 | 5 | 13 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 5.99e-05 | 5 | 13 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 5.99e-05 | 5 | 13 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 5.99e-05 | 5 | 13 | 2 | HP:0032823 | |
| HumanPheno | Normal interictal EEG | 8.97e-05 | 6 | 13 | 2 | HP:0002372 | |
| HumanPheno | Eyelid myoclonia seizure | 1.25e-04 | 7 | 13 | 2 | HP:0032678 | |
| HumanPheno | Focal autonomic seizure | 3.26e-04 | 11 | 13 | 2 | HP:0011154 | |
| HumanPheno | Neonatal seizure | 3.26e-04 | 11 | 13 | 2 | HP:0032807 | |
| HumanPheno | Increased theta frequency activity in EEG | 3.26e-04 | 11 | 13 | 2 | HP:0031535 | |
| HumanPheno | Focal automatism seizure | 3.91e-04 | 12 | 13 | 2 | HP:0032898 | |
| HumanPheno | Facial tics | 6.20e-04 | 15 | 13 | 2 | HP:0011468 | |
| MousePheno | abnormal afterhyperpolarization | 4.29e-06 | 17 | 27 | 3 | MP:0003412 | |
| Domain | K_chnl_volt-dep_KCNQ | 3.54e-11 | 5 | 32 | 4 | IPR003937 | |
| Domain | KCNQ_channel | 3.54e-11 | 5 | 32 | 4 | PF03520 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 3.54e-11 | 5 | 32 | 4 | IPR013821 | |
| Domain | VG_K_chnl | 2.80e-07 | 33 | 32 | 4 | IPR028325 | |
| Domain | Ion_trans_dom | 1.37e-06 | 114 | 32 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.37e-06 | 114 | 32 | 5 | PF00520 | |
| Domain | KCNQC3-Ank-G_bd | 2.84e-06 | 2 | 32 | 2 | PF11956 | |
| Domain | Ankyrin-G_BS | 2.84e-06 | 2 | 32 | 2 | IPR020969 | |
| Domain | K_chnl_volt-dep_KCNQ2 | 2.84e-06 | 2 | 32 | 2 | IPR003947 | |
| Domain | TBC | 3.18e-03 | 49 | 32 | 2 | SM00164 | |
| Domain | RabGAP-TBC | 3.71e-03 | 53 | 32 | 2 | PF00566 | |
| Domain | adh_short | 3.99e-03 | 55 | 32 | 2 | PF00106 | |
| Domain | TBC_RABGAP | 3.99e-03 | 55 | 32 | 2 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 3.99e-03 | 55 | 32 | 2 | IPR000195 | |
| Domain | Nucleotide-diphossugar_trans | 9.93e-03 | 88 | 32 | 2 | IPR029044 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 1.22e-08 | 15 | 26 | 4 | M22002 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.07e-06 | 43 | 26 | 4 | M1056 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 3.55e-05 | 103 | 26 | 4 | M1073 | |
| Pathway | WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS | 1.17e-04 | 9 | 26 | 2 | M48307 | |
| Pathway | WP_KCNQ2RELATED_EPILEPSIES | 5.49e-04 | 19 | 26 | 2 | M48320 | |
| Pubmed | The contribution of Kv7 channels to pregnant mouse and human myometrial contractility. | 4.83e-12 | 5 | 36 | 4 | 20132415 | |
| Pubmed | Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase. | 4.83e-12 | 5 | 36 | 4 | 15304482 | |
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 26969140 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 12890507 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 18786918 | ||
| Pubmed | 4.07e-09 | 4 | 36 | 3 | 10713961 | ||
| Pubmed | A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly. | 4.07e-09 | 4 | 36 | 3 | 12524525 | |
| Pubmed | 2.03e-08 | 6 | 36 | 3 | 12032157 | ||
| Pubmed | 2.03e-08 | 6 | 36 | 3 | 21730298 | ||
| Pubmed | 8.60e-08 | 40 | 36 | 4 | 16382104 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15608631 | ||
| Pubmed | Benign neonatal sleep myoclonus: an autosomal dominant form not allelic to KCNQ2 or KCNQ3. | 1.04e-06 | 2 | 36 | 2 | 22447848 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 16319223 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19453707 | ||
| Pubmed | Pathogenic plasticity of Kv7.2/3 channel activity is essential for the induction of tinnitus. | 1.04e-06 | 2 | 36 | 2 | 23716673 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 18166285 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10025409 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 23650395 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 32580997 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 18483067 | ||
| Pubmed | Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. | 1.04e-06 | 2 | 36 | 2 | 9872318 | |
| Pubmed | KCNQ channels show conserved ethanol block and function in ethanol behaviour. | 1.04e-06 | 2 | 36 | 2 | 23209695 | |
| Pubmed | KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. | 1.04e-06 | 2 | 36 | 2 | 9836639 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 38049972 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24843134 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10684873 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25740509 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 23002961 | ||
| Pubmed | Expression and localization of K channels KCNQ2 and KCNQ3 in the mammalian cochlea. | 1.04e-06 | 2 | 36 | 2 | 18827480 | |
| Pubmed | Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents. | 1.04e-06 | 2 | 36 | 2 | 18536747 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 16235065 | ||
| Pubmed | Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. | 1.04e-06 | 2 | 36 | 2 | 10953053 | |
| Pubmed | Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells. | 1.04e-06 | 2 | 36 | 2 | 11159685 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 16721610 | ||
| Pubmed | Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels. | 1.04e-06 | 2 | 36 | 2 | 16990515 | |
| Pubmed | Novel role of KCNQ2/3 channels in regulating neuronal cell viability. | 1.04e-06 | 2 | 36 | 2 | 20885443 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10713399 | ||
| Pubmed | Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. | 1.04e-06 | 2 | 36 | 2 | 10908292 | |
| Pubmed | KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3. | 1.04e-06 | 2 | 36 | 2 | 35320039 | |
| Pubmed | The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement. | 1.04e-06 | 2 | 36 | 2 | 22334706 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24333508 | ||
| Pubmed | Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation. | 1.04e-06 | 2 | 36 | 2 | 15483133 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 12832524 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 12640002 | ||
| Pubmed | Direct neurotransmitter activation of voltage-gated potassium channels. | 1.04e-06 | 2 | 36 | 2 | 29748663 | |
| Pubmed | KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. | 1.04e-06 | 2 | 36 | 2 | 18625963 | |
| Pubmed | KCNQ Potassium Channels Modulate Sensitivity of Skin Down-hair (D-hair) Mechanoreceptors. | 1.04e-06 | 2 | 36 | 2 | 26733196 | |
| Pubmed | Inactivation as a new regulatory mechanism for neuronal Kv7 channels. | 1.04e-06 | 2 | 36 | 2 | 17237198 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 18089837 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19389803 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31871302 | ||
| Pubmed | Vestibular role of KCNQ4 and KCNQ5 K+ channels revealed by mouse models. | 1.04e-06 | 2 | 36 | 2 | 23408425 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 14534157 | ||
| Pubmed | Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. | 1.04e-06 | 2 | 36 | 2 | 10854243 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27607834 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 26627826 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 37607817 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 29474891 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10479678 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20437616 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9677360 | ||
| Pubmed | Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents. | 1.04e-06 | 2 | 36 | 2 | 19060215 | |
| Pubmed | DNA methylation and expression of KCNQ3 in bipolar disorder. | 1.04e-06 | 2 | 36 | 2 | 25041603 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10788442 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21466805 | ||
| Pubmed | SMIT1 Modifies KCNQ Channel Function and Pharmacology by Physical Interaction with the Pore. | 3.12e-06 | 3 | 36 | 2 | 28793216 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24375629 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 20861226 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 37801083 | ||
| Pubmed | Structural Insights into the M-Channel Proximal C-Terminus/Calmodulin Complex. | 3.12e-06 | 3 | 36 | 2 | 27564677 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30885609 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 34509475 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26312501 | ||
| Pubmed | Sodium and potassium channel dysfunctions in rare and common idiopathic epilepsy syndromes. | 3.12e-06 | 3 | 36 | 2 | 19464834 | |
| Pubmed | Kv7 channels can function without constitutive calmodulin tethering. | 3.12e-06 | 3 | 36 | 2 | 21980481 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 14762142 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24297175 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24719109 | ||
| Pubmed | M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit. | 3.12e-06 | 3 | 36 | 2 | 11034315 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 20377416 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 21976501 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 17519950 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 23360469 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16525039 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 30467111 | ||
| Pubmed | Chromosomal mapping of the potassium channel genes Kcnq2 and Kcnq3 in mouse. | 6.24e-06 | 4 | 36 | 2 | 10087209 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 7.72e-06 | 37 | 36 | 3 | 25798587 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 23259949 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 25998125 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.30e-05 | 139 | 36 | 4 | 16985003 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.39e-05 | 1105 | 36 | 8 | 35748872 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 10781098 | ||
| Pubmed | Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels. | 1.56e-05 | 6 | 36 | 2 | 12223552 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 27445338 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 24838176 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 30382937 | ||
| Pubmed | 1.58e-04 | 18 | 36 | 2 | 37321992 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 3.48e-04 | 132 | 36 | 3 | 16944949 | |
| Pubmed | 7.66e-04 | 401 | 36 | 4 | 25852190 | ||
| Pubmed | 9.16e-04 | 43 | 36 | 2 | 19077034 | ||
| Interaction | KCNQ3 interactions | 6.18e-08 | 24 | 33 | 4 | int:KCNQ3 | |
| Interaction | KCNS1 interactions | 4.76e-07 | 10 | 33 | 3 | int:KCNS1 | |
| Interaction | KCNQ5 interactions | 2.31e-05 | 34 | 33 | 3 | int:KCNQ5 | |
| Cytoband | 19q13 | 2.74e-04 | 31 | 36 | 2 | 19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 2.11e-03 | 325 | 36 | 3 | chr9q34 | |
| Cytoband | 9q34.3 | 3.16e-03 | 106 | 36 | 2 | 9q34.3 | |
| Cytoband | 7q34 | 7.64e-03 | 167 | 36 | 2 | 7q34 | |
| GeneFamily | Potassium voltage-gated channels | 1.76e-07 | 40 | 23 | 4 | 274 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.90e-03 | 51 | 23 | 2 | 870 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 4.17e-03 | 76 | 23 | 2 | 743 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 5.42e-03 | 87 | 23 | 2 | 372 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3 | 2.09e-06 | 396 | 33 | 7 | GSM605799_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3 | 1.06e-05 | 331 | 33 | 6 | GSM538329_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d100.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.85e-05 | 365 | 33 | 6 | GSM605904_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.97e-05 | 369 | 33 | 6 | GSM605891_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 2.32e-05 | 380 | 33 | 6 | GSM605901_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1+.Th, aGC CD1d tet CD3e CD44 NK1.1, Thymus, avg-3 | 2.50e-05 | 385 | 33 | 6 | GSM538332_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3 | 2.89e-05 | 395 | 33 | 6 | GSM476678_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d-tetramer CD4, Spleen, avg-2 | 1.52e-04 | 333 | 33 | 5 | GSM538323_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3+25+.Sp, 4+ 8- GFP+ 25+, Spleen, avg-3 | 1.77e-04 | 344 | 33 | 5 | GSM399365_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d tetramer CD4, Spleen, avg-1 | 1.84e-04 | 347 | 33 | 5 | GSM538322_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Lv, CD45 TCRb aGalCer-loaded CD1d tet CD4, Liver, avg-4 | 1.92e-04 | 350 | 33 | 5 | GSM538318_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 1.95e-04 | 351 | 33 | 5 | GSM538325_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 2.22e-04 | 361 | 33 | 5 | GSM538385_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 2.39e-04 | 367 | 33 | 5 | GSM538401_500 | |
| CoexpressionAtlas | NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3 | 2.55e-04 | 372 | 33 | 5 | GSM538288_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 2.67e-04 | 376 | 33 | 5 | GSM605894_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 2.91e-04 | 383 | 33 | 5 | GSM538403_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 3.05e-04 | 387 | 33 | 5 | GSM538392_500 | |
| CoexpressionAtlas | NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | 3.17e-04 | 390 | 33 | 5 | GSM538291_500 | |
| CoexpressionAtlas | NK cells, NK.DAP12-.Sp, NK1.1+ CD3-, Spleen, avg-3 | 3.64e-04 | 402 | 33 | 5 | GSM538297_500 | |
| CoexpressionAtlas | NK cells, NK.Sp, NK1.1+, Spleen, avg-3 | 3.94e-04 | 409 | 33 | 5 | GSM538315_500 | |
| CoexpressionAtlas | NK cells, NK.49H-.Sp, NK1.1+, Spleen, avg-3 | 4.12e-04 | 413 | 33 | 5 | GSM605817_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_100 | 5.81e-04 | 23 | 33 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k4 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-06 | 159 | 36 | 4 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-06 | 159 | 36 | 4 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | COVID-19_Severe-Treg|World / disease group, cell group and cell class | 8.51e-06 | 161 | 36 | 4 | c6eade2c60c572d823e6e81b5e8d47078671e9b0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-06 | 165 | 36 | 4 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-06 | 165 | 36 | 4 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-06 | 165 | 36 | 4 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 170 | 36 | 4 | 26178277bf9c7f2f06b5c0b03d4b69d78e9580c4 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 1.05e-05 | 170 | 36 | 4 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 172 | 36 | 4 | b440184f2d98d2f2d59566795f44fb79c0647ca4 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 174 | 36 | 4 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-05 | 174 | 36 | 4 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 175 | 36 | 4 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 179 | 36 | 4 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 191 | 36 | 4 | 4aa29337f4d2528577bb90dc4abfb6eab93e120f | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 191 | 36 | 4 | 318323a12029a7992f16382cb0c186f5b2e1ca47 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 194 | 36 | 4 | ad1aacff97beb76f4211942676e1d5e84087d44e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 194 | 36 | 4 | fdd59b1e036b2d6d8877e1a920a0e56a91a2a882 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-05 | 196 | 36 | 4 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.37e-04 | 124 | 36 | 3 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 137 | 36 | 3 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.83e-04 | 137 | 36 | 3 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.83e-04 | 137 | 36 | 3 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-04 | 149 | 36 | 3 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 152 | 36 | 3 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 152 | 36 | 3 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.58e-04 | 154 | 36 | 3 | 08ffa4b6f4a1c3de037acf9d30bd14c195738ad9 | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 2.58e-04 | 154 | 36 | 3 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-04 | 156 | 36 | 3 | 7ece590fd8f29382e349dd0e5e016d2926aeb518 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 2.68e-04 | 156 | 36 | 3 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | Control-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.73e-04 | 157 | 36 | 3 | 4803f601c1ba43260aa09172acc7964aac2c8ccf | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 159 | 36 | 3 | 796e63f6052189106359a4e01eae3e466bf1d593 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 162 | 36 | 3 | 08ee7ae56e4927874515c47adc86dd845bf29a26 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 162 | 36 | 3 | b46158e260bd2f35702cec73e3b035e8e9ec4469 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 162 | 36 | 3 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | d18fee517e0daed51f89703f94f218567c83cb03 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 3.05e-04 | 163 | 36 | 3 | 4eac7fd8acdb7f09ce739335f22a879f9b8febfb | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | f4a6e28ad3c1fcbf62ed9b2bf09f65d2ab0b31d1 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 163 | 36 | 3 | 9f5facfa1864eb63e2f8022ad7379d9252b7a254 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | 8569abb769543be55e066119c1dd1c505d5a177e | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | b175258fb0885afd84d4a414c0ae441f880e8469 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-04 | 164 | 36 | 3 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 164 | 36 | 3 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | 8bcfc93220d7c99dddb32b7fa7fb9aec2a1c63fa | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 165 | 36 | 3 | 6708beb0e8094f30cf5cd812e6a67a6db004a580 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-04 | 165 | 36 | 3 | 1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.16e-04 | 165 | 36 | 3 | fbc7d97e6f30975d35c76a7c97947a34cf5975d2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 166 | 36 | 3 | dbb73742db00982539b1800aef8af2801b3a0598 | |
| ToppCell | -SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.22e-04 | 166 | 36 | 3 | bc9323de1373fdc0357e6bb46874f6c4787443a9 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 166 | 36 | 3 | fc2cf67311c86fda75b35fcd4768b6f6f14c59d0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 166 | 36 | 3 | b7027802cac6ebf3c4a19ef11c9164d92694a4eb | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 166 | 36 | 3 | 33a6876d06e26176135a73a77c19e634ec53f7ce | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 168 | 36 | 3 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 168 | 36 | 3 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 168 | 36 | 3 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 168 | 36 | 3 | 110c3c7c322e04a684a19c2b5434a502279fd000 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 168 | 36 | 3 | 735d30cfda1889740bdeb43e39330a52e8f4d599 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.39e-04 | 169 | 36 | 3 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | droplet-Liver-Npc|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | 09c836840216905d545a25a4fc1bbd0699576c77 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 170 | 36 | 3 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 170 | 36 | 3 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 170 | 36 | 3 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | bcbe5c44ef708c5f01dc7dd9aec7b436e1a62d56 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 170 | 36 | 3 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.51e-04 | 171 | 36 | 3 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 171 | 36 | 3 | 1064c20c37fae6cefb2eb4fa0628e4037a78179c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 171 | 36 | 3 | 246fc7edcefc47437d1df6029f295aca3b34b2b2 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 171 | 36 | 3 | 872b3b33cd3893d63c45617db0269692430b0e8b | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 171 | 36 | 3 | e2b72282244dee008e3b5d03667be9f26b7c2f6d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 171 | 36 | 3 | 1fb4e11f92b48dc2d6e553c22e2571bbd8c223c6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 172 | 36 | 3 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 172 | 36 | 3 | e04b1788f2074e66dff00cac734c8ee2cfefca6e | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 172 | 36 | 3 | f45489e80c59b824846ffda675de0d118a8b850c | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.57e-04 | 172 | 36 | 3 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-04 | 172 | 36 | 3 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 172 | 36 | 3 | 30f4979abf0218618a56afb06aa6afc23ad838ec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 172 | 36 | 3 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 173 | 36 | 3 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 6bb98b0776151d726c2962a96f3411213aa86b21 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-04 | 173 | 36 | 3 | 28c98a9a54aa2cfa67464db4f628c9357ad185b9 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 173 | 36 | 3 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | 87fa5deff5c1aabb342d674f05ad17c4c0e50d01 | |
| ToppCell | Control-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 3.70e-04 | 174 | 36 | 3 | 522a6d5d9809271c63b85f62ac6ec52a6e3c355e | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | 919fc124affc69acfd8f575f2c372674f3d2625e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-04 | 174 | 36 | 3 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-04 | 175 | 36 | 3 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-04 | 175 | 36 | 3 | f1d91cd49308cb501864cd16befaa43d6da828ca | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | a7269351ce6afbd469c79174aa88be84d4f7e0b6 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.76e-04 | 175 | 36 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | 1fa85b28d0e4d1d8d584516325a46f69dc6fbe54 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | f12e230a7d0d265542c5698231a3eb0876ac4cc8 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.76e-04 | 175 | 36 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | 046e841811b22c39f80a9752f3223c1906de6f20 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 176 | 36 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 3.82e-04 | 176 | 36 | 3 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| Drug | Quinazolinones | 2.07e-11 | 5 | 34 | 4 | ctd:D052999 | |
| Drug | N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide | 6.20e-11 | 6 | 34 | 4 | ctd:C476437 | |
| Drug | isovaleramide | 2.89e-10 | 8 | 34 | 4 | CID000010930 | |
| Drug | eslicarbazepine acetate | 2.89e-10 | 8 | 34 | 4 | CID000179344 | |
| Drug | valrocemide | 2.89e-10 | 8 | 34 | 4 | CID006918293 | |
| Drug | BMS-204352 | 2.93e-09 | 13 | 34 | 4 | CID000214350 | |
| Drug | ezogabine | 3.04e-09 | 3 | 34 | 3 | ctd:C101866 | |
| Drug | benzanilide | 7.45e-09 | 16 | 34 | 4 | CID000007168 | |
| Drug | carisbamate | 7.45e-09 | 16 | 34 | 4 | CID006918474 | |
| Drug | Thallium | 2.97e-08 | 22 | 34 | 4 | ctd:D013793 | |
| Drug | CCD 1042 | 5.13e-08 | 25 | 34 | 4 | CID000038022 | |
| Drug | sotalol | 7.63e-08 | 73 | 34 | 5 | CID000005253 | |
| Drug | rufinamide | 9.58e-08 | 29 | 34 | 4 | CID000129228 | |
| Drug | valnoctamide | 1.27e-07 | 31 | 34 | 4 | CID000020140 | |
| Drug | XE991 | 1.64e-07 | 33 | 34 | 4 | CID000656732 | |
| Drug | LY 300164 | 4.91e-07 | 43 | 34 | 4 | CID000126756 | |
| Drug | linopirdine | 4.91e-07 | 43 | 34 | 4 | CID000003932 | |
| Drug | AC1Q646P | 7.06e-07 | 47 | 34 | 4 | CID000005673 | |
| Drug | Pro-val | 7.06e-07 | 47 | 34 | 4 | CID000142984 | |
| Drug | retigabine | 7.70e-07 | 48 | 34 | 4 | CID000121892 | |
| Drug | lacosamide | 1.07e-06 | 52 | 34 | 4 | CID000219078 | |
| Drug | E 4031 | 1.24e-06 | 54 | 34 | 4 | CID000003184 | |
| Drug | LMWH | 4.60e-06 | 663 | 34 | 8 | CID000000772 | |
| Drug | linopirdine | 6.49e-06 | 3 | 34 | 2 | ctd:C061017 | |
| Drug | (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide | 6.49e-06 | 3 | 34 | 2 | ctd:C576869 | |
| Drug | verapamil | 6.66e-06 | 490 | 34 | 7 | CID000002520 | |
| Drug | PGF-MUM | 1.30e-05 | 4 | 34 | 2 | CID006443310 | |
| Drug | 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone | 1.30e-05 | 4 | 34 | 2 | ctd:C112297 | |
| Drug | kinin 9 | 1.45e-05 | 363 | 34 | 6 | CID000006026 | |
| Drug | diazoxide | 2.07e-05 | 227 | 34 | 5 | CID000003019 | |
| Drug | niflumic acid | 3.53e-05 | 125 | 34 | 4 | CID000004488 | |
| Drug | dobutamine | 5.50e-05 | 140 | 34 | 4 | CID000036811 | |
| Drug | Diclofenac | 6.03e-05 | 8 | 34 | 2 | DB00586 | |
| Drug | Magnesium Sulfate | 6.03e-05 | 8 | 34 | 2 | ctd:D008278 | |
| Drug | DiC8 | 6.48e-05 | 146 | 34 | 4 | CID000001323 | |
| Drug | tremorine | 7.74e-05 | 9 | 34 | 2 | CID000005534 | |
| Drug | potassium | 9.32e-05 | 1008 | 34 | 8 | CID000000813 | |
| Drug | Benzimidazoles | 9.67e-05 | 10 | 34 | 2 | ctd:D001562 | |
| Drug | histamine | 1.61e-04 | 560 | 34 | 6 | CID000000774 | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A | 1.83e-04 | 191 | 34 | 4 | 2041_UP | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4623_UP | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 4636_UP | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; HL60; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 3135_UP | |
| Drug | Acrylamide | 2.14e-04 | 199 | 34 | 4 | ctd:D020106 | |
| Drug | bicyclo-PGE2 | 2.25e-04 | 15 | 34 | 2 | CID005283043 | |
| Drug | glibenclamide | 2.41e-04 | 382 | 34 | 5 | CID000003488 | |
| Drug | norsolorinic acid | 2.90e-04 | 17 | 34 | 2 | CID000025102 | |
| Drug | adenosine 3',5'-cyclic phosphate | 3.26e-04 | 907 | 34 | 7 | CID000000274 | |
| Drug | meclofenamate | 3.72e-04 | 94 | 34 | 3 | CID000004036 | |
| Drug | tetraethylammonium | 4.09e-04 | 236 | 34 | 4 | CID000005413 | |
| Disease | long QT syndrome (implicated_via_orthology) | 3.07e-10 | 10 | 34 | 4 | DOID:2843 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.04e-09 | 13 | 34 | 4 | DOID:0112202 (implicated_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 5.16e-08 | 32 | 34 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | Benign neonatal seizures | 1.29e-06 | 2 | 34 | 2 | cv:C0220669 | |
| Disease | benign neonatal seizures (implicated_via_orthology) | 1.29e-06 | 2 | 34 | 2 | DOID:14264 (implicated_via_orthology) | |
| Disease | benign neonatal seizures (is_implicated_in) | 3.86e-06 | 3 | 34 | 2 | DOID:14264 (is_implicated_in) | |
| Disease | Familial benign neonatal epilepsy | 1.93e-05 | 6 | 34 | 2 | C0220669 | |
| Disease | Ischemia | 4.78e-04 | 28 | 34 | 2 | C0022116 | |
| Disease | Alcoholic Intoxication | 6.25e-04 | 32 | 34 | 2 | C0001969 | |
| Disease | diverticulitis | 8.37e-04 | 37 | 34 | 2 | EFO_1001460 | |
| Disease | beta-nerve growth factor measurement | 1.08e-03 | 42 | 34 | 2 | EFO_0008035 | |
| Disease | Pneumonia | 1.78e-03 | 54 | 34 | 2 | C0032285 | |
| Disease | Experimental Lung Inflammation | 1.78e-03 | 54 | 34 | 2 | C0887898 | |
| Disease | Pneumonitis | 1.78e-03 | 54 | 34 | 2 | C3714636 | |
| Disease | Lobar Pneumonia | 1.78e-03 | 54 | 34 | 2 | C0032300 | |
| Disease | Bipolar Disorder | 2.13e-03 | 477 | 34 | 4 | C0005586 | |
| Disease | Allergic Reaction | 2.41e-03 | 63 | 34 | 2 | C1527304 | |
| Disease | Hypersensitivity | 2.48e-03 | 64 | 34 | 2 | C0020517 | |
| Disease | rheumatoid arthritis (is_marker_for) | 2.88e-03 | 69 | 34 | 2 | DOID:7148 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RERMWMLLLRLGCPN | 326 | P49682 | |
| WRMRVSLARALFMEP | 456 | Q8NE71 | |
| KMPVALLRRRMSVWL | 686 | Q9UJX6 | |
| RTRANSMEGLMPRWV | 571 | O43306 | |
| RGMQRWMLPLRRGAR | 156 | Q8N9P6 | |
| MERMNWLSRLASRGP | 1 | Q8N612 | |
| RMLRMDRRGGTWKLL | 236 | O43525 | |
| RMVRMDRRGGTWKLL | 241 | Q9NR82 | |
| ILRMVRMDRRGGTWK | 211 | P56696 | |
| LRMIRMDRRGGTWKL | 206 | O43526 | |
| MSRRSMLLAWALPSL | 1 | O75594 | |
| PLADDRSRSLLMWML | 261 | A6NFY4 | |
| ARDMWVMETGLLLPR | 236 | P15391 | |
| MRMAPTESTEGRRLW | 1 | Q6ZTY9 | |
| MGRPRPRAAKTWMFL | 1 | O60259 | |
| PDRRERMLASLWEME | 331 | Q5T4B2 | |
| TQWRGMGLSLMRLDR | 501 | P49327 | |
| RLFRPWLNMDRMLRS | 116 | O15382 | |
| MARPGMERWRDRLAL | 1 | Q6UWP2 | |
| LMGMELFEEALRRWE | 211 | Q8NAN2 | |
| MAASMARRLWPLLTR | 1 | Q9NP81 | |
| WMREFIQLAGRVMLP | 281 | Q08AM6 | |
| AFRWMNNLLMRELPL | 406 | Q9NU19 | |
| MAGPRPRWRDQLLFM | 1 | Q9NV12 | |
| MDGWRRMPRWGLLLL | 1 | P00797 | |
| DRRLWMEAMDGREPV | 356 | Q9UNA1 | |
| MLRTAMGLRSWLAAP | 1 | Q9NPR2 | |
| GLIRWMLMVNPDRRA | 281 | O60285 | |
| IPRALRRTLMAAMAW | 276 | Q96DW6 | |
| MAVRSRRPWMSVALG | 1 | Q70JA7 | |
| RRSLPMLFRMEWGCA | 156 | P49763 | |
| TLPMLPWLMAEIRRR | 51 | O60343 | |
| ERLWGLTEMFPERVR | 46 | Q9NS69 | |
| MSWYRQDPGMGLRLI | 51 | A0A0A6YYG3 | |
| MLPEWLRSRFRMGEL | 706 | Q8NET8 | |
| MSWYRQDPGMGLRLI | 51 | A0A0K0K1A5 |